Preparation for reconstruction influenza A H1N1 virus inactivated vaccine strain (SC/PR8), and use thereof
A technology of influenza virus and inactivated vaccines, which is applied in the direction of viruses/bacteriophages, antiviral agents, and medical preparations containing active ingredients, etc., which can solve the problems of short immunization period, difficulty, and high cost of vaccines
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0058] Embodiment 1: Screening, establishment of identification recombinant virus method
[0059] Using the TrIzol strong fission agent method, extract the RNA of influenza virus A / PR / 8 / 34 (H1N1) and influenza A H1N1 influenza isolate A / SC / 1 / 2009 (H1N1), carry out reverse transcription, and then use the above-mentioned design The fragment-specific identification primers of influenza virus A / PR / 8 / 34 (H1N1) and influenza A H1N1 influenza isolate A / SC / 1 / 2009 (H1N1) were used for PCR reaction. The fragment-specific identification primers designed according to the gene of influenza virus A / PR / 8 / 34 (H1N1) can only amplify 8 specific fragments of influenza virus A / PR / 8 / 34 (H1N1) strain but cannot amplify Add any fragments of the A / SC / 1 / 2009 (H1N1) strain of the A / SC / 1 / 2009 (H1N1) influenza strain, and fragment-specific identification primers designed according to the gene of the A / SC / 1 / 2009 (H1N1) influenza A / H1N1 influenza isolate Only 8 specific fragments of influenza A / SC / 1 / 2009 ...
Embodiment 2
[0063] Example 2: Preparation and Identification of Recombinant Influenza A H1N1 Virus
[0064] 1. Co-infection - Recombination of two viral genomes:
[0065] 100 μl of influenza A H1N1 domestic isolate strain A / SC / 1 / 2009 (H1N1) and 50 μl of influenza virus A / PR / 8 / 34 (H1N1) (PR8 for short) were mixed and added to 850 μl of PBS, and co-inoculated at 10 days old The allantoic cavity of SPF chicken embryos undergoes natural reorganization. After culturing at 35°C for 24 hours, the allantoic fluid was collected.
[0066] 2. Antibody screening-removal of strains whose surface genes are derived from influenza virus A / PR / 8 / 34 (H1N1):
[0067] Take 50 μl of the allantoic fluid harvested under the above-mentioned specific artificial conditions and mix with 600 μl of anti-A / PR / 8 / 34 (H1N1) antiserum diluted by 4 times, react at room temperature for 30 minutes, and then inoculate each dilution Three chicken embryos. Next, the inoculated chicken embryos were cultured in a 35°C incubato...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com